No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study.
第一作者:
Akarin,Hiransuthikul
第一单位:
Institute of HIV Research and Innovation (IHRI), Bangkok, Thailand.;Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
作者:
医学主题词
成年人(Adult);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);青年人(Young Adult);腺嘌呤(Adenine);投药, 口服(Administration, Oral);抗HIV药(Anti-HIV Agents);乙酸环丙孕酮(Cyproterone Acetate);药物相互作用(Drug Interactions);雌二醇(Estradiol);HIV感染(HIV Infections);泰国(Thailand);丙氨酸(Alanine)
DOI
10.1002/jia2.26502
PMID
40390323
发布时间
2025-07-28
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



